US5427940A
(en)
*
|
1991-06-03 |
1995-06-27 |
Board Of Regents, The University Of Texas System |
Engineered cells producing insulin in response to glucose
|
US5744327A
(en)
*
|
1990-02-20 |
1998-04-28 |
Board Of Regents, The University Of Texas System |
Methods for producing insulin in response to non-glucose secretagogues
|
US5792656A
(en)
*
|
1991-06-03 |
1998-08-11 |
Board Of Regents, The University Of Texas System |
Methods of preparing genetically engineered cells that produce insulin in response to glucose
|
US5571787A
(en)
|
1993-07-30 |
1996-11-05 |
Myelos Corporation |
Prosaposin as a neurotrophic factor
|
WO1995005452A2
(en)
*
|
1993-08-12 |
1995-02-23 |
Cytotherapeutics, Inc. |
Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5908623A
(en)
*
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5550050A
(en)
|
1994-04-15 |
1996-08-27 |
Cytotherapeutics, Inc. |
Method for implanting encapsulated cells in a host
|
US5670347A
(en)
|
1994-05-11 |
1997-09-23 |
Amba Biosciences Llc |
Peptide-mediated gene transfer
|
US5853717A
(en)
*
|
1994-07-20 |
1998-12-29 |
Cytotherapeutics, Inc. |
Methods and compositions of growth control for cells encapsulated within bioartificial organs
|
JP2001506226A
(ja)
*
|
1995-05-12 |
2001-05-15 |
ザ ロックフェラー ユニヴァーシティ |
シナプシンのモジュレーションによるアルツハイマー病の治療法
|
IN181898B
(no)
*
|
1995-06-07 |
1998-10-24 |
Cytotherapeutics Inc |
|
US7279313B2
(en)
*
|
1995-09-15 |
2007-10-09 |
Centelion |
Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
|
FR2738842B1
(fr)
*
|
1995-09-15 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique
|
US7364894B2
(en)
*
|
1995-09-15 |
2008-04-29 |
Centelion |
Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
WO1997012635A1
(en)
*
|
1995-10-02 |
1997-04-10 |
Cytotherapeutics, Inc. |
Method for treating amyotrophic lateral sclerosis
|
US5855613A
(en)
*
|
1995-10-13 |
1999-01-05 |
Islet Sheet Medical, Inc. |
Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
|
US5929041A
(en)
*
|
1996-02-23 |
1999-07-27 |
Amgen Inc. |
Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
|
US5837681A
(en)
*
|
1996-02-23 |
1998-11-17 |
Amgen Inc. |
Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US6224912B1
(en)
*
|
1996-04-03 |
2001-05-01 |
The Rogo Institute |
Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
|
US7297331B2
(en)
*
|
1996-04-03 |
2007-11-20 |
The Rogosin Institute |
Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
|
US6210664B1
(en)
|
1996-04-08 |
2001-04-03 |
New York University Medical Center |
Method for gene transfer to the central nervous system
|
WO1997038707A1
(en)
*
|
1996-04-17 |
1997-10-23 |
Cytotherapeutics, Inc. |
Method and device for delivery of apoptosis-inducing molecules
|
US7138251B1
(en)
|
1996-04-22 |
2006-11-21 |
Amgen Inc. |
Polynucleotides encoding a neurotrophic factor receptor
|
US6027721A
(en)
*
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
US5945100A
(en)
*
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
US6054142A
(en)
|
1996-08-01 |
2000-04-25 |
Cyto Therapeutics, Inc. |
Biocompatible devices with foam scaffolds
|
US6150164A
(en)
*
|
1996-09-30 |
2000-11-21 |
The Regents Of The University Of Michigan |
Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
|
US6593290B1
(en)
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US6156728A
(en)
*
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
CA2277955A1
(en)
*
|
1997-01-23 |
1998-07-30 |
Michiko Kishino |
Remedies for diabetes
|
US5844077A
(en)
*
|
1997-04-28 |
1998-12-01 |
Cytotherapeutics, Inc. |
Use of conantokins for producing analgesia or for neuroprotection
|
US6042579A
(en)
*
|
1997-04-30 |
2000-03-28 |
Medtronic, Inc. |
Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
|
AU7165998A
(en)
*
|
1997-05-30 |
1998-12-30 |
Amgen, Inc. |
Neurotrophic factor receptors
|
US6254865B1
(en)
|
1997-06-17 |
2001-07-03 |
University Technology Corporation |
Method of treating huntington's disease using HNT neurons
|
US6167888B1
(en)
*
|
1997-06-30 |
2001-01-02 |
The Regents Of The University Of California |
Method for inducing partial recovery of lost voluntary motor function after spinal cord injury in a mammal
|
ZA986077B
(en)
|
1997-07-09 |
2000-01-10 |
Genentech Inc |
ErbB4 receptor-specific neuregulin related ligands and uses therefor.
|
US6121415A
(en)
|
1997-07-09 |
2000-09-19 |
Genentech, Inc. |
ErbB4 receptor-specific neuregolin related ligands and uses therefor
|
US6469311B1
(en)
|
1997-07-16 |
2002-10-22 |
Molecular Devices Corporation |
Detection device for light transmitted from a sensed volume
|
US6071748A
(en)
|
1997-07-16 |
2000-06-06 |
Ljl Biosystems, Inc. |
Light detection device
|
US6994856B1
(en)
|
1997-07-24 |
2006-02-07 |
Genentech, Inc. |
ErbB4 receptor-specific neuregulin related ligands and uses therefor
|
US6043221A
(en)
*
|
1997-07-30 |
2000-03-28 |
Amgen Inc. |
Method for preventing and treating hearing loss using a neuturin protein product
|
US6042909A
(en)
*
|
1997-09-03 |
2000-03-28 |
Circe Biomedical, Inc. |
Encapsulation device
|
US7745142B2
(en)
|
1997-09-15 |
2010-06-29 |
Molecular Devices Corporation |
Molecular modification assays
|
US6326605B1
(en)
|
1998-02-20 |
2001-12-04 |
Ljl Biosystems, Inc. |
Broad range light detection system
|
US6825921B1
(en)
|
1999-11-10 |
2004-11-30 |
Molecular Devices Corporation |
Multi-mode light detection system
|
US6576476B1
(en)
|
1998-09-02 |
2003-06-10 |
Ljl Biosystems, Inc. |
Chemiluminescence detection method and device
|
US6297018B1
(en)
|
1998-04-17 |
2001-10-02 |
Ljl Biosystems, Inc. |
Methods and apparatus for detecting nucleic acid polymorphisms
|
US6156729A
(en)
|
1997-10-15 |
2000-12-05 |
California Institute Of Technology |
Leukemia inhibitory factor for use in modulating inflammation and pain
|
US6485901B1
(en)
*
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
CA2305787A1
(en)
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
CA2245224A1
(en)
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
US6946445B1
(en)
|
1998-03-13 |
2005-09-20 |
The University Of British Columbia |
Therapeutic chemokine receptor antagonists
|
US6277820B1
(en)
|
1998-04-09 |
2001-08-21 |
Genentech, Inc. |
Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells
|
US6303136B1
(en)
|
1998-04-13 |
2001-10-16 |
Neurotech S.A. |
Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
|
WO1999057248A1
(en)
*
|
1998-04-30 |
1999-11-11 |
President And Fellows Of Harvard College |
Induction of neuronal regeneration
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
WO2000004927A1
(en)
*
|
1998-07-24 |
2000-02-03 |
Alleghney University Of The Health Sciences |
Allogeneic cellular immunogens useful as cancer vaccines
|
AU5223899A
(en)
|
1998-07-27 |
2000-02-21 |
Ljl Biosystems, Inc. |
Apparatus and methods for spectroscopic measurements
|
AU5667599A
(en)
|
1998-07-27 |
2000-02-21 |
Ljl Biosystems, Inc. |
Apparatus and methods for time-resolved spectroscopic measurements
|
US20020115213A1
(en)
*
|
1998-08-14 |
2002-08-22 |
Northeastern Ohio Universities Of Medicine |
Engraftable neural progenitor & stem cells for brain tumor therapy
|
PL348517A1
(en)
*
|
1998-09-09 |
2002-06-03 |
Myelos Corp |
Method of stimulating prosaposin receptor activity
|
JP2002524468A
(ja)
*
|
1998-09-09 |
2002-08-06 |
ミエロスコーポレーション |
プロサポシン受容体活性を刺激する方法
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
US6156514A
(en)
*
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
US6303749B1
(en)
|
1999-01-29 |
2001-10-16 |
Amgen Inc. |
Agouti and agouti-related peptide analogs
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
US7708993B2
(en)
*
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
JP5000804B2
(ja)
*
|
1999-02-03 |
2012-08-15 |
アムジエン・インコーポレーテツド |
免疫応答に関与する新規ポリペプチド
|
US6713293B1
(en)
|
1999-02-08 |
2004-03-30 |
Friedrich Grummt |
Encapsulated cells containing an amplified expression vector as a drug delivery device
|
IL138990A0
(en)
*
|
1999-02-12 |
2001-11-25 |
Biostream Inc |
Matrices for drug delivery and methods for making and using the same
|
AU3005400A
(en)
|
1999-02-23 |
2000-09-14 |
Ljl Biosystems, Inc. |
Frequency-domain light detection device
|
US6903244B1
(en)
|
1999-02-26 |
2005-06-07 |
University Of Utah Research Foundation |
Mice which are +/− or −/− for the elastin gene as models for vascular disease
|
US6303355B1
(en)
|
1999-03-22 |
2001-10-16 |
Duke University |
Method of culturing, cryopreserving and encapsulating pancreatic islet cells
|
US6365385B1
(en)
|
1999-03-22 |
2002-04-02 |
Duke University |
Methods of culturing and encapsulating pancreatic islet cells
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
WO2000058479A1
(en)
|
1999-03-26 |
2000-10-05 |
Amgen Inc. |
Beta secretase genes and polypeptides
|
US20070071734A1
(en)
*
|
1999-04-06 |
2007-03-29 |
Weng Tao |
ARPE-19 as platform cell line for encapsulated cell-based delivery
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
CA2381292C
(en)
|
1999-08-05 |
2016-05-24 |
Mcl Llc |
Multipotent adult stem cells and methods for isolation
|
US8147824B2
(en)
|
1999-08-05 |
2012-04-03 |
Athersys, Inc. |
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
|
US7408047B1
(en)
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US6878543B1
(en)
|
1999-10-25 |
2005-04-12 |
Nsgene Sa |
Cultures of GFAP+ nestin+ cells that differentiate to neurons
|
US6267954B1
(en)
|
1999-11-24 |
2001-07-31 |
Universite De Paris V Rene-Descartes |
Intraocular transplantation of encapsulated cells
|
US7060676B2
(en)
*
|
1999-12-20 |
2006-06-13 |
Trustees Of Tufts College |
T. cruzi-derived neurotrophic agents and methods of use therefor
|
US6458118B1
(en)
|
2000-02-23 |
2002-10-01 |
Medtronic, Inc. |
Drug delivery through microencapsulation
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US7368425B2
(en)
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
US20050059584A1
(en)
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
US7378098B2
(en)
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
AU7026601A
(en)
|
2000-06-28 |
2002-01-08 |
Amgen Inc |
Thymic stromal lymphopoietin receptor molecules and uses thereof
|
MXPA02012718A
(es)
*
|
2000-06-28 |
2003-10-06 |
Amgen Inc |
Moleculas semejantes a b7 y sus usos.
|
US6538010B1
(en)
*
|
2000-11-08 |
2003-03-25 |
Research Triangle Institute |
Compounds and methods for promoting smoking cessation
|
EP1337634A2
(en)
|
2000-11-28 |
2003-08-27 |
Amgen Inc. |
Novel polypeptides involved in immune response
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US7276580B2
(en)
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
AU2002305079B8
(en)
*
|
2001-05-11 |
2006-05-25 |
Ortho-Mcneil Pharmaceutical, Inc. |
Immune modulation device for use in animals
|
ES2339339T3
(es)
*
|
2001-06-22 |
2010-05-19 |
Universite Catholique De Louvain |
Perlas o capsulas de hidrogel como medios artificiales para la oviposicion de insectos y la cria de endoparasitoides.
|
EP1281767A3
(en)
*
|
2001-07-31 |
2003-05-28 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of tumors
|
US7332330B2
(en)
|
2001-09-11 |
2008-02-19 |
Renamed Biologics, Inc. |
Device for maintaining vascularization near an implant
|
US7981863B2
(en)
*
|
2001-09-19 |
2011-07-19 |
Neuronova Ab |
Treatment of Parkinson's disease with PDGF
|
DE10164039A1
(de)
*
|
2001-12-28 |
2003-07-10 |
Nmi Univ Tuebingen |
Implantierbare Vorrichtung und deren Verwendung
|
US7662924B2
(en)
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US7442546B2
(en)
*
|
2002-03-15 |
2008-10-28 |
The Regents Of The University Of Michigan |
Method of modulating inflammatory response
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
DK1458853T3
(da)
|
2002-05-16 |
2010-04-06 |
Absorber Ab |
Fremgangsmåde til donorspecifik krydsmatchning
|
EP1369491A1
(en)
*
|
2002-06-05 |
2003-12-10 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
US20030228261A1
(en)
*
|
2002-06-05 |
2003-12-11 |
Aladar Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
DK1541674T3
(da)
*
|
2002-06-18 |
2011-03-14 |
Eisai R&D Man Co Ltd |
Primære dyrkede adipocyter til genterapi
|
US7276057B2
(en)
*
|
2002-09-06 |
2007-10-02 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
|
US7328069B2
(en)
*
|
2002-09-06 |
2008-02-05 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
|
US7427280B2
(en)
|
2002-09-06 |
2008-09-23 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
|
US7328068B2
(en)
*
|
2003-03-31 |
2008-02-05 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
|
US7369894B2
(en)
*
|
2002-09-06 |
2008-05-06 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
|
US7618948B2
(en)
*
|
2002-11-26 |
2009-11-17 |
Medtronic, Inc. |
Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US7605249B2
(en)
*
|
2002-11-26 |
2009-10-20 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
AU2002952993A0
(en)
|
2002-11-29 |
2002-12-12 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
Therapeutic and diagnostic agents
|
US20040230182A1
(en)
*
|
2002-12-27 |
2004-11-18 |
Medtronic, Inc. |
Drug delivery through encapsulation
|
US7994149B2
(en)
|
2003-02-03 |
2011-08-09 |
Medtronic, Inc. |
Method for treatment of Huntington's disease through intracranial delivery of sirna
|
US7732591B2
(en)
*
|
2003-11-25 |
2010-06-08 |
Medtronic, Inc. |
Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
|
CA2864810A1
(en)
|
2003-04-18 |
2004-11-04 |
Biogen Idec Ma, Inc. |
Polymer-conjugated glycosylated neublastin
|
US7459152B2
(en)
*
|
2003-04-23 |
2008-12-02 |
Rush University Medical Center |
Erythropoietin administration to improve graft survival
|
JP4879742B2
(ja)
|
2003-05-16 |
2012-02-22 |
ユニヴェルシテ ラヴァル |
Cnsクロライドの調節およびその使用
|
DK1636260T3
(da)
|
2003-06-10 |
2009-06-22 |
Biogen Idec Inc |
Forbedret udskillelse af Neublastin
|
AU2004289953B2
(en)
*
|
2003-06-18 |
2008-09-25 |
Genelux Corporation |
Modified recombinant vaccina viruses and other microorganisms, uses thereof
|
WO2005020677A1
(en)
|
2003-08-29 |
2005-03-10 |
The Walter And Eliza Hall Institute Of Medical Research |
Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening
|
KR20060095568A
(ko)
|
2003-10-20 |
2006-08-31 |
엔에스진 에이/에스 |
파킨슨병의 생체내 유전자 요법
|
CA2551189A1
(en)
|
2003-12-24 |
2005-07-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Therapeutic agents and uses therefor
|
ES2315842T3
(es)
*
|
2004-01-19 |
2009-04-01 |
Nsgene A/S |
Celulas terapeuticas humanas que secretan factor de crecimiento nervioso.
|
US8467875B2
(en)
|
2004-02-12 |
2013-06-18 |
Medtronic, Inc. |
Stimulation of dorsal genital nerves to treat urologic dysfunctions
|
US20050208090A1
(en)
*
|
2004-03-18 |
2005-09-22 |
Medtronic, Inc. |
Methods and systems for treatment of neurological diseases of the central nervous system
|
KR101204286B1
(ko)
*
|
2004-03-30 |
2012-11-26 |
엔에스진 에이/에스 |
성장 인자 NsG33의 치료학적 용도
|
JP4980211B2
(ja)
|
2004-05-12 |
2012-07-18 |
ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ |
細胞単離方法
|
EP1753439A2
(en)
|
2004-05-17 |
2007-02-21 |
Regents Of The University Of Minnesota |
Use of umbilical cord blood stem cells to treat ischemic event
|
WO2006013462A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Nsgene A/S |
Growth factors nsg28, nsg30, and nsg32
|
CN101043899B
(zh)
|
2004-08-19 |
2011-03-30 |
比奥根艾迪克Ma公司 |
重折叠转化型生长因子beta家族蛋白
|
MX2007002029A
(es)
|
2004-08-19 |
2007-03-28 |
Biogen Idec Inc |
Variantes de neublastina.
|
US20060099193A1
(en)
*
|
2004-10-22 |
2006-05-11 |
Ikuko Sugaya |
Methods and materials for suppressing pain
|
MX2007012155A
(es)
|
2005-04-01 |
2008-04-04 |
Nsgene As |
Linea celular precursora neural inmortalizada humana.
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
WO2006118547A1
(en)
|
2005-04-29 |
2006-11-09 |
Agency For Science, Technology And Research |
Hyperbranched polymers and their applications
|
US20090022785A1
(en)
*
|
2005-05-03 |
2009-01-22 |
Veterinarmedizinische Universitat Wien |
Permeable Capsules
|
US20060257368A1
(en)
*
|
2005-05-03 |
2006-11-16 |
Clemson University |
Devices and methods for improved viability of cells
|
US7902352B2
(en)
*
|
2005-05-06 |
2011-03-08 |
Medtronic, Inc. |
Isolated nucleic acid duplex for reducing huntington gene expression
|
US20060257912A1
(en)
*
|
2005-05-06 |
2006-11-16 |
Medtronic, Inc. |
Methods and sequences to suppress primate huntington gene expression
|
CA2609000C
(en)
|
2005-05-17 |
2015-01-13 |
Nsgene A/S |
An implantable therapy system for treating a living being with an active factor
|
US20090169523A1
(en)
|
2005-06-13 |
2009-07-02 |
Catherine Verfaillie |
Hsc self-renewal
|
CN101248177B
(zh)
|
2005-06-24 |
2012-09-05 |
沃尔特及伊莱萨霍尔医学研究院 |
治疗性促凋亡bh3样分子和用于产生和/或选择它的方法
|
US9133517B2
(en)
*
|
2005-06-28 |
2015-09-15 |
Medtronics, Inc. |
Methods and sequences to preferentially suppress expression of mutated huntingtin
|
US20080280843A1
(en)
*
|
2006-05-24 |
2008-11-13 |
Van Bilsen Paul |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
US8357666B2
(en)
|
2005-08-01 |
2013-01-22 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through RNA interference
|
CN101253199B
(zh)
|
2005-08-30 |
2019-06-14 |
迈阿密大学 |
免疫调节肿瘤坏死因子受体25(tnfr25)的激动剂、拮抗剂和免疫毒素
|
US9388382B2
(en)
*
|
2005-10-05 |
2016-07-12 |
The Board Of Trustees Of The University Of Illinois |
Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
|
AU2006308312A1
(en)
*
|
2005-10-28 |
2007-05-03 |
Nsgene A/S |
Implantable Biocompatible Immunoisolatory Vehicle for Delivery of GDNF
|
US11000546B2
(en)
|
2005-11-09 |
2021-05-11 |
Athersys, Inc. |
Immunomodulatory properties of MAPCs and uses thereof
|
US10117900B2
(en)
*
|
2005-11-09 |
2018-11-06 |
Athersys, Inc. |
MAPC treatment of brain injuries and diseases
|
AP2809A
(en)
|
2005-11-18 |
2013-12-31 |
Glenmark Pharmaceuticals Sa |
Anti-Alpha2 Integrin antibodies and their uses
|
CA2635534C
(en)
|
2005-12-30 |
2014-07-29 |
Neurotech Usa Inc. |
Micronized device for the delivery of biologically active molecules and methods of use thereof
|
NZ570614A
(en)
|
2006-01-23 |
2012-07-27 |
Athersys Inc |
Multipotent adult progenitor cell treatment of brain injuries and diseases
|
CN101410126A
(zh)
|
2006-01-23 |
2009-04-15 |
阿特西斯公司 |
无附加的免疫抑制治疗的mapc治疗法
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
CN106434527A
(zh)
|
2006-04-14 |
2017-02-22 |
安斯泰来再生医药协会 |
血管瘤集落形成细胞
|
US20070255333A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Medtronic, Inc. |
Neuromodulation therapy for perineal or dorsal branch of pudendal nerve
|
US9273356B2
(en)
|
2006-05-24 |
2016-03-01 |
Medtronic, Inc. |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
AU2007275764B2
(en)
|
2006-07-18 |
2013-11-14 |
University Of Utah Research Foundation |
Methods for treating pain and screening analgesic compounds
|
US20080039415A1
(en)
*
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
US8835163B2
(en)
*
|
2006-10-18 |
2014-09-16 |
The Board Of Trustees Of The University Of Illinois |
Embryonic-like stem cells derived from adult human peripheral blood and methods of use
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
US9375440B2
(en)
*
|
2006-11-03 |
2016-06-28 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
US7819842B2
(en)
*
|
2006-11-21 |
2010-10-26 |
Medtronic, Inc. |
Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites
|
US7988668B2
(en)
*
|
2006-11-21 |
2011-08-02 |
Medtronic, Inc. |
Microsyringe for pre-packaged delivery of pharmaceuticals
|
US20080171906A1
(en)
*
|
2007-01-16 |
2008-07-17 |
Everaerts Frank J L |
Tissue performance via hydrolysis and cross-linking
|
US8545834B2
(en)
*
|
2007-03-15 |
2013-10-01 |
The Mclean Hospital Corporation |
G-substrate for the treatment and prevention of parkinson's disease
|
KR101812400B1
(ko)
|
2007-04-03 |
2017-12-27 |
옥시레인 유케이 리미티드 |
분자의 글리코실화
|
EP2142205B1
(en)
|
2007-05-01 |
2014-04-02 |
Biogen Idec MA Inc. |
Neublastin peptides for use in increasing vascularisation in tissue with impaired blood flow
|
EP2185730A4
(en)
|
2007-08-23 |
2010-10-27 |
Intrexon Corp |
METHOD AND COMPOSITIONS FOR SICKNESS DIAGNOSIS
|
WO2009029508A1
(en)
*
|
2007-08-28 |
2009-03-05 |
Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute, Inc. |
Intracranial catheter and methods of use
|
NZ584848A
(en)
|
2007-09-28 |
2012-09-28 |
Intrexon Corp |
Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
|
EP2592148B1
(en)
|
2007-10-12 |
2018-09-12 |
F. Hoffmann-La Roche AG |
Protein expression from multiple nucleic acids
|
WO2009092092A1
(en)
|
2008-01-18 |
2009-07-23 |
Regents Of The University Of Minnesota |
Stem cell aggregates and methods for making and using
|
US20090196854A1
(en)
*
|
2008-02-04 |
2009-08-06 |
Kytos Biosystems S.A. |
Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
|
WO2009125332A1
(en)
*
|
2008-04-07 |
2009-10-15 |
Peter Bromley |
New and safe procedure for immunization against infectious diseases agents
|
AU2009234424A1
(en)
|
2008-04-07 |
2009-10-15 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through use of an HDAC modulator
|
CA3150872A1
(en)
|
2008-05-06 |
2009-11-12 |
Astellas Institute For Regenerative Medicine |
Methods for producing enucleated erythroid cells derived from pluripotent stem cells
|
CA2722693C
(en)
|
2008-05-06 |
2023-03-21 |
Advanced Cell Technology, Inc. |
Hemangio colony forming cells and non-engrafting hemangio cells
|
WO2009140649A2
(en)
*
|
2008-05-16 |
2009-11-19 |
Mclean Hosptial |
Rab3b for the treatment and prevention of parkinson's disease
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
EP2195013B1
(en)
|
2008-07-24 |
2011-11-02 |
NsGene A/S |
Therapeutic use of a growth factor, metrnl
|
US9540630B2
(en)
*
|
2008-09-17 |
2017-01-10 |
Beta O2 Technologies Ltd. |
Optimization of alginate encapsulation of islets for transplantation
|
SG195542A1
(en)
|
2008-10-10 |
2013-12-30 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
WO2010075500A1
(en)
|
2008-12-23 |
2010-07-01 |
Stemcells California, Inc |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
US20120021039A1
(en)
|
2009-01-23 |
2012-01-26 |
Nsgene A/S |
Expression of neuropeptides in mammalian cells
|
AU2010206374B2
(en)
*
|
2009-01-23 |
2013-01-17 |
Gloriana Therapeutics Sarl |
Improved cell lines and their use in encapsulated cell biodelivery
|
US9511093B2
(en)
|
2009-03-23 |
2016-12-06 |
The Texas A & M University System |
Compositions of mesenchymal stem cells to regenerate bone
|
EP2421981B1
(en)
*
|
2009-04-23 |
2013-08-14 |
Neurotech USA, Inc. |
Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
|
WO2010129600A2
(en)
|
2009-05-05 |
2010-11-11 |
Amgen Inc. |
Fgf21 mutants and uses thereof
|
DK3248610T3
(da)
|
2009-05-05 |
2024-01-15 |
Amgen Inc |
Fgf21-mutanter og anvendelser deraf
|
BRPI0902039B8
(pt)
|
2009-06-09 |
2021-05-25 |
Anhanguera Educacional Ltda |
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
|
KR102033276B1
(ko)
|
2009-08-03 |
2019-10-16 |
유니버시티 오브 마이애미 |
T 조절 세포의 생체 내 확장 방법
|
BR112012007099A2
(pt)
|
2009-09-29 |
2015-09-15 |
Oxyrane Uk Ltd |
hidrólise da ligação manose-1-fosfo-6-manose a fosfo-manose
|
WO2011044216A1
(en)
*
|
2009-10-08 |
2011-04-14 |
Neurotech Usa, Inc. |
Use of pedf in an encapsulated cell-based delivery system
|
CA2781240A1
(en)
|
2009-11-19 |
2011-05-26 |
Oxyrane Uk Limited |
Yeast strains producing mammalian-like complex n-glycans
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
US20110238036A1
(en)
*
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
CA2791331A1
(en)
|
2010-02-25 |
2011-09-01 |
Abt Holding Company |
Modulation of angiogenesis
|
SG10201501402UA
(en)
|
2010-02-25 |
2015-04-29 |
Abt Holding Co |
Modulation of macrophage activation
|
EP2558497A2
(en)
|
2010-04-15 |
2013-02-20 |
Amgen Inc. |
Human fgf receptor and beta-klotho binding proteins
|
EP2563907B1
(en)
|
2010-04-28 |
2019-06-19 |
The J. David Gladstone Institutes |
Methods for generating cardiomyocytes
|
EP2568991B3
(en)
|
2010-05-12 |
2018-11-28 |
ABT Holding Company |
Modulation of splenocytes in cell therapy
|
WO2011154941A2
(en)
|
2010-06-07 |
2011-12-15 |
Beta-O2 Technologies Ltd. |
Multiple-layer immune barrier for donor cells
|
WO2011159726A2
(en)
|
2010-06-14 |
2011-12-22 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
US9475709B2
(en)
|
2010-08-25 |
2016-10-25 |
Lockheed Martin Corporation |
Perforated graphene deionization or desalination
|
JP6151183B2
(ja)
|
2010-09-29 |
2017-06-21 |
オキシレイン ユーケー リミテッド |
マンノース−1−ホスホ−6−マンノース結合からキャップを外すことおよびリン酸化n−グリカンを脱マンノシル化することができるマンノシダーゼならびに哺乳動物細胞による糖タンパク質の取り込みを促進する方法
|
KR101979220B1
(ko)
|
2010-09-29 |
2019-05-16 |
옥시레인 유케이 리미티드 |
인산화된 n-글리칸들의 탈-만노실화
|
ES2584068T3
(es)
|
2010-10-01 |
2016-09-23 |
Nsgene A/S |
Uso de meteorina para el tratamiento de alodinia, hiperalgesia, dolor espontáneo y dolor fantasma
|
US8815942B2
(en)
|
2010-10-20 |
2014-08-26 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
|
US9539324B2
(en)
|
2010-12-01 |
2017-01-10 |
Alderbio Holdings, Llc |
Methods of preventing inflammation and treating pain using anti-NGF compositions
|
US9067988B2
(en)
|
2010-12-01 |
2015-06-30 |
Alderbio Holdings Llc |
Methods of preventing or treating pain using anti-NGF antibodies
|
US9884909B2
(en)
|
2010-12-01 |
2018-02-06 |
Alderbio Holdings Llc |
Anti-NGF compositions and use thereof
|
US11214610B2
(en)
|
2010-12-01 |
2022-01-04 |
H. Lundbeck A/S |
High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
|
US9078878B2
(en)
|
2010-12-01 |
2015-07-14 |
Alderbio Holdings Llc |
Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
|
US8728473B2
(en)
|
2010-12-01 |
2014-05-20 |
Alderbio Holdings Llc |
Methods of preventing or treating pain using anti-NGF antibodies
|
ES2613302T3
(es)
|
2010-12-02 |
2017-05-23 |
Neurotech Usa, Inc. |
Líneas celulares que segregan estructuras de anticuerpos anti-angiogénicas y receptores solubles y usos de los mismos
|
CN104093830A
(zh)
|
2011-04-15 |
2014-10-08 |
吉恩勒克斯公司 |
减毒的痘苗病毒的克隆毒株及其使用方法
|
SG195302A1
(en)
|
2011-06-06 |
2013-12-30 |
Kineta One Llc |
Shk-based pharmaceutical compositions and methods of manufacturing and using the same
|
JP6145667B2
(ja)
|
2011-09-05 |
2017-06-14 |
ホーバ セラピューティクス アンパルトセルスカブ |
アロディニア、痛覚過敏、自発痛、及び幻痛の治療
|
CA2867237C
(en)
|
2012-03-15 |
2024-01-02 |
Wouter Vervecken |
Methods and materials for treatment of pompe's disease
|
US10696554B2
(en)
|
2015-08-06 |
2020-06-30 |
Lockheed Martin Corporation |
Nanoparticle modification and perforation of graphene
|
US9744617B2
(en)
|
2014-01-31 |
2017-08-29 |
Lockheed Martin Corporation |
Methods for perforating multi-layer graphene through ion bombardment
|
US10980919B2
(en)
|
2016-04-14 |
2021-04-20 |
Lockheed Martin Corporation |
Methods for in vivo and in vitro use of graphene and other two-dimensional materials
|
US10653824B2
(en)
|
2012-05-25 |
2020-05-19 |
Lockheed Martin Corporation |
Two-dimensional materials and uses thereof
|
US9834809B2
(en)
|
2014-02-28 |
2017-12-05 |
Lockheed Martin Corporation |
Syringe for obtaining nano-sized materials for selective assays and related methods of use
|
US9610546B2
(en)
|
2014-03-12 |
2017-04-04 |
Lockheed Martin Corporation |
Separation membranes formed from perforated graphene and methods for use thereof
|
JP2015519370A
(ja)
|
2012-05-30 |
2015-07-09 |
ニューロテック ユーエスエー, インコーポレイテッド |
低温保存される植込み型細胞培養デバイスおよびその使用
|
EP2879684B1
(en)
|
2012-08-01 |
2019-01-30 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
|
EP2879682B1
(en)
|
2012-08-01 |
2018-03-21 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
EP2943253B1
(en)
|
2013-01-09 |
2021-10-20 |
University Of Miami |
Compositions and methods for the regulation of t regulatory cells using tl1a-ig fusion protein and il-2
|
EP3878452B1
(en)
|
2013-01-09 |
2023-09-20 |
United Therapeutics Corporation |
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
|
WO2014136065A2
(en)
|
2013-03-05 |
2014-09-12 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|
JP6234485B2
(ja)
|
2013-03-07 |
2017-11-22 |
ヴィアサイト インコーポレイテッド |
3次元大収容力細胞封入デバイスアセンブリー
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
US9592475B2
(en)
|
2013-03-12 |
2017-03-14 |
Lockheed Martin Corporation |
Method for forming perforated graphene with uniform aperture size
|
JOP20140087B1
(ar)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
بروتينات مخصصة ل baff و b7rp1 وإستخداماتها
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
CA2909267C
(en)
|
2013-04-12 |
2022-10-25 |
Saverio LA FRANCESCA |
Improving organs for transplantation
|
EP2992088B1
(en)
|
2013-04-30 |
2019-08-21 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
KR20160019469A
(ko)
|
2013-05-31 |
2016-02-19 |
더 유니버시티 오브 유타 리서치 파운데이션 |
코노톡신 펩티드, 제약 조성물 및 그의 용도
|
US9572918B2
(en)
|
2013-06-21 |
2017-02-21 |
Lockheed Martin Corporation |
Graphene-based filter for isolating a substance from blood
|
EP3043836B1
(en)
|
2013-09-11 |
2023-05-10 |
Neurotech USA, Inc. |
Encapsulated cell therapy cartridge
|
WO2015042580A1
(en)
|
2013-09-23 |
2015-03-26 |
Biogen Idec Ma Inc. |
Compositions and methods for treatment of neuropathic pain
|
WO2015116946A1
(en)
|
2014-01-31 |
2015-08-06 |
Lockheed Martin Corporation |
Perforating two-dimensional materials using broad ion field
|
CA2938305A1
(en)
|
2014-01-31 |
2015-08-06 |
Lockheed Martin Corporation |
Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
|
AU2015229331A1
(en)
|
2014-03-12 |
2016-10-27 |
Lockheed Martin Corporation |
Separation membranes formed from perforated graphene
|
CN107073408A
(zh)
|
2014-09-02 |
2017-08-18 |
洛克希德马丁公司 |
基于二维膜材料的血液透析膜和血液过滤膜及其应用方法
|
WO2016036322A1
(en)
*
|
2014-09-04 |
2016-03-10 |
Kemijski inštitut |
Cell-based device for local treatment with therapeutic protein
|
ES2833457T3
(es)
|
2015-05-27 |
2021-06-15 |
Neurotech Usa Inc |
Uso de terapia con células encapsuladas para el tratamiento del glaucoma
|
AU2016303048A1
(en)
|
2015-08-05 |
2018-03-01 |
Lockheed Martin Corporation |
Perforatable sheets of graphene-based material
|
WO2017070738A1
(en)
|
2015-10-27 |
2017-05-04 |
The University Of Queensland |
A method of treatment and agents useful for same
|
JP2019517909A
(ja)
|
2016-04-14 |
2019-06-27 |
ロッキード・マーチン・コーポレーション |
流路を有する二次元膜構造体
|
EP3443329A4
(en)
|
2016-04-14 |
2020-04-08 |
Lockheed Martin Corporation |
METHODS FOR PROVIDING IN SITU MONITORING AND CONTROL OF DEFECT TRAINING OR HEALING
|
SG11201809016QA
(en)
|
2016-04-14 |
2018-11-29 |
Lockheed Corp |
Selective interfacial mitigation of graphene defects
|
WO2017180135A1
(en)
|
2016-04-14 |
2017-10-19 |
Lockheed Martin Corporation |
Membranes with tunable selectivity
|
CA3020686A1
(en)
|
2016-04-14 |
2017-10-19 |
Lockheed Martin Corporation |
Method for treating graphene sheets for large-scale transfer using free-float method
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
EP3272877A1
(en)
|
2016-07-18 |
2018-01-24 |
ETH Zurich |
B-cell-mimetic cells
|
KR20190026786A
(ko)
|
2016-07-18 |
2019-03-13 |
에테하 취리히 |
β-세포-모방 세포
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
AU2017350732B2
(en)
|
2016-10-24 |
2023-07-27 |
United Therapeutics Corporation |
Enhancement of MSC immunomodulatory properties by treprostinil
|
WO2018089011A1
(en)
|
2016-11-10 |
2018-05-17 |
Viacyte, Inc |
Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof
|
NZ756132A
(en)
|
2017-03-10 |
2022-02-25 |
Hoffmann La Roche |
Method for producing multispecific antibodies
|
EP3658204A4
(en)
|
2017-07-24 |
2021-06-23 |
California Institute of Technology |
REMOVABLE, CHEMICALLY AMPLIFIED, LOW POWER ELECTRICAL BARRIER
|
EP3656851A1
(en)
|
2018-11-23 |
2020-05-27 |
Technische Universität Dresden |
Artificial hla-positive feeder cell lines for nk cells and uses thereof
|
WO2022011081A1
(en)
|
2020-07-09 |
2022-01-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cell lines that produce human retinoschisin proteins and uses thereof
|
WO2022081760A1
(en)
|
2020-10-14 |
2022-04-21 |
Sana Biotechnology, Inc. |
Hepatocyte-like cells
|
IT202100006569A1
(it)
|
2021-03-18 |
2022-09-18 |
Hemera S R L |
Metodo per ottenere macrofagi rigenerativi educati dal tumore e loro uso nella medicina rigenerativa
|
WO2023081420A1
(en)
|
2021-11-05 |
2023-05-11 |
Abt Holding Company |
Culture-expanded canine progenitor cells and related methods
|
WO2023164171A2
(en)
|
2022-02-25 |
2023-08-31 |
Viacyte, Inc. |
Multilayer implantable cell encapsulation devices and methods thereof
|